HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin J Humphries Selected Research

Martin J Humphries Research Topics

Disease

12Neoplasms (Cancer)
07/2023 - 08/2002
4Wounds and Injuries (Trauma)
01/2024 - 03/2009
3Melanoma (Melanoma, Malignant)
07/2023 - 09/2003
2Fibrosis (Cirrhosis)
07/2021 - 08/2012
2Neoplasm Metastasis (Metastasis)
01/2021 - 10/2007
2Breast Neoplasms (Breast Cancer)
01/2021 - 08/2002
1Necrosis
01/2023
1Rupture
01/2023
1Adenocarcinoma
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Kidney Diseases (Kidney Disease)
07/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Carcinogenesis
01/2021
1Squamous Cell Carcinoma of Head and Neck
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2020
1Insulin Resistance
01/2020
1Pathologic Processes
07/2015
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2014
1Bone Fractures (Bone Fracture)
03/2009
1Arthritis (Polyarthritis)
10/2005
1Inflammation (Inflammations)
10/2005
1Fibrosarcoma
10/2002
1Carcinoma (Carcinomatosis)
08/2002

Drug/Important Bio-Agent (IBA)

11IntegrinsIBA
07/2023 - 08/2002
6Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2003
3Syndecan-4IBA
01/2024 - 10/2011
2Peptides (Polypeptides)IBA
01/2024 - 12/2023
2Paclitaxel (Taxol)FDA LinkGeneric
07/2023 - 01/2020
2Small Interfering RNA (siRNA)IBA
01/2020 - 01/2005
2Integrin alpha5beta1IBA
11/2009 - 10/2007
1Protein Isoforms (Isoforms)IBA
07/2023
1SmokeIBA
01/2023
1HydrogelsIBA
01/2022
1ProteomeIBA
07/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2021
1Lapatinib (GW572016)FDA Link
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1Coloring Agents (Dyes)IBA
01/2021
1PoisonsIBA
01/2020
1Vincristine (Oncovin)FDA LinkGeneric
01/2020
1Insulin (Novolin)FDA Link
01/2020
1Biomarkers (Surrogate Marker)IBA
08/2012
1CaveolinsIBA
10/2011
1sharpinIBA
09/2011
1SyndecansIBA
03/2009
1GTP Phosphohydrolases (GTPases)IBA
10/2007
1Fibronectins (Fibronectin)IBA
10/2007
1Integrin beta1IBA
10/2007
1Heparin (Liquaemin)FDA LinkGeneric
10/2006
1S 16197IBA
10/2005
1S 18407IBA
10/2005
1ProdrugsIBA
10/2005
1Urokinase Plasminogen Activator ReceptorsIBA
01/2005
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2005
1Fibrillin-1IBA
09/2003
1FibrillinsIBA
09/2003
1arginyl-glycyl-aspartic acidIBA
09/2003
1Monoclonal AntibodiesIBA
10/2002
1Cadherins (E-Cadherin)IBA
10/2002
1AntibodiesIBA
10/2002
1Integrin alpha2IBA
10/2002
1Amino AcidsFDA Link
08/2002
1Protein Kinase CIBA
08/2002
1Epidermal Growth Factor (EGF)IBA
08/2002
1Phorbol EstersIBA
08/2002

Therapy/Procedure

4Therapeutics
07/2023 - 03/2009
1Ligation
10/2007